420 with CNW – Pros and Cons of Different CBD Drinks

If you have been paying attention to the cannabis space for the past few years, you must have heard of cannabidiol or CBD, a chemical extracted from cannabis that is taking the world by storm. One of its biggest attractions is that it doesn’t create a psychoactive high, meaning users can use it for its health benefits and stay clear-headed. And it has a ton of medical benefits, with studies finding it effective against a myriad of conditions such as anxiety, chronic pain, and high blood pressure.

There are plenty of ways you can consume cannabis, such as smoking cannabis flower, ingesting it through gummies and other confectioneries, and applying it topically. In fact, CBD gummies were the third most searched for food by Americans in 2018, and CBD-infused drinks are quickly emerging as the next best thing in the CBD/cannabis space. They are accessible, easy to administer, and a lot safer than alcohol and other energy drinks.

CBD coffee, for instance, can be found in many restaurants and coffee shops, and you can buy your own CBD oil and make your own CBD coffee at home. Although coffee helps perk you up and keeps you alert, it can also increase your heart rate and cause headaches and anxiety. CBD has been proven to reduce anxiety and improve circulatory health, making it a perfect counter for coffee’s more unpleasant effects.

Like cannabidiol-infused coffee, CBD water has been around for a while, and it is just as simple to consume. The CBD is infused in the water through nano emulsion technology and it needs no extra preparation once purchased. However, most brands infuse the minimum level of CBD (2-5mg) in the water, so you’ll need a higher dose of CBD water for the health benefits to kick in. Studies suggest at least 15mg of CBD every day. You may also want to avoid buying from supermarkets as the CBD particles will degrade when exposed to light and air on the shelves, thereby making them less effective.

You may also be interested in CBD cocktails, which take unwinding and relaxation to a whole other level. CBD oil’s earthy, plant-like taste makes it a great addition to gin and amaro-based cocktails, and the combination will leave you feeling relaxed and mellowed out. CBD alcohol may also alleviate anxiety and insomnia while eliminating the dreaded hangover. However, there has been little research on CBD cocktails’ particular effect on the body. You will also have to limit your intake as this is alcohol after all, and it is only good in moderation.

As you can see, your options of CBD drinks are increasing by the day, and analysts say sector players like Champignon Brands Inc. (CSE: SHRM) (OTCQB: SHRM) (FWB: 496) may be working behind the scenes to increase the options even more.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW – Bermuda Government Seeks Public Feedback on Marijuana Legalization Bill

Last year, Bermudan lawmakers released a draft bill aimed at creating a legal cannabis program and asked the public to offer pertinent feedback. The draft legislation was met with criticism from the public as people felt it imposed excessive regulations, and they argued that the territory should legalize marijuana altogether for adult use. On Wednesday, the government of Bermuda released a draft bill to establish a legal marijuana market, and it is again seeking feedback from the public.

Under the proposed bill, adults 21 and older would be able to possess and purchase up to seven grams of marijuana from licensed retailers. The bill would require the creation of a Cannabis Advisory Authority, and it would be responsible for issuing licenses and regulating the market. Cultivation, retail, research, import, export, transportation, and manufacturing licenses will be up for grabs, and individuals with prior marijuana convictions will not be denied access.

According to a summary of the bill, fees for the licenses would be designed to help stimulate the industry while making them affordable enough for ‘under-served and marginalized communities.’ People with prior convictions for possessing seven grams or less of marijuana would also be eligible for expungement of their criminal records.

“Surprising for some, public attitudes have evolved apace with global legislative reforms, and in recognition that opening up pathways for new economic opportunities and activity is needed,” said Attorney General Kathy Simmons in a video on the proposal. The government is requesting public input on the proposed legislation up until July 3. A prompt on its website asks individuals seven specific questions that the government needs feedback on, including licensing requirements and penalties.

“The government has made a commitment to progressively liberalize cannabis laws in Bermuda and to create economic opportunities for citizens wishing to participate in a regulated cannabis scheme,” states the website. “The Government again wishes to ‘take it to the people’ by commencing a one-month public consultation exercise on the proposed scheme.”

In her video, Attorney General Simmons said that the government plans to move ahead with a more simplified, regulated, cannabis scheme, which builds on the strength of the original medical cannabis policy and which embraces the public feedback. “The revised proposal will provide for a regulated cannabis program which has been hybridized to meet Bermuda’s requirements while modeling the best available legal provisions in Canada, both Provincial and federal and to a lesser degree, examples from the Caribbean.”

One would be forgiven for imagining that industry players like The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) long for the day when the U.S. federal government conducts a similar consultative exercise geared at legalizing marijuana federally.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

HempNewsBreaks – SinglePoint, Inc. (SING) Drives Headlines, Reaches New Heights from Solar to Hemp

SinglePoint (OTCQB: SING) today shared the most recent headlines the company has generated in the news. According to the update, SinglePoint is achieving new sales and record revenue in Q1 2020, with solar being a driving force leading the company’s growth. The release includes a detailed list and links to news generated by the company as it reaches new heights and gains brand recognition for its offerings that range from solar to hemp and sanitizer.

To view the full press release, visit http://cnw.fm/Cm4Ep

About SinglePoint, Inc.

Founded in 2011, SinglePoint, Inc. invests in and acquires brands and companies that will benefit from injection of growth capital and its sales and marketing expertise. The company’s portfolio currently includes solar, hemp and technology applications. SinglePoint is working to grow the company to a multi-national brand. For more information, visit the company’s website at www.SinglePoint.com.

NOTE TO INVESTORS: The latest news and updates relating to SING are available in the company’s newsroom at http://cnw.fm/SING

About HempWire

HempWire (HW) is a dedicated information provider focused on (1) aggregating hemp-related news, (2) issuing HempNewsBreaks designed to update investors on the latest developments in the hemp market, (3) enhancing corporate news releases, (4) providing full-service distribution and social media offerings to public and private client-partners and (5) designing and implementing all-inclusive corporate communication solutions. HW is strategically positioned within the rapidly expanding hemp sector with a team of journalists working to help a growing roster of public and private companies reach a wide audience of investors, consumers and members of the media. We leverage a vast network of more than 5,000 key syndication outlets to deliver unparalleled visibility, recognition and content to the hemp industry. HempWire (HW) is where HEMP news, content and information converge.

To receive instant SMS alerts, text HEMPWIRE to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.HempWire.com

Please see full terms of use and disclaimers on the HempWire website applicable to all content provided by HW, wherever published or re-published: https://www.HempWire.com/Disclaimer

Do you have questions or are you interested in working with HW? Ask our Editor

HempWire (HW)
Denver, Colorado
www.HempWire.com

303.498.7722

Office
Editor@HempWire.net

HempWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Cannabis Strategic Ventures, Inc. (NUGS) Embarks on New Phase to Further Capacity and Quality at NUGS Farm

Cannabis Strategic Ventures (OTCQB: NUGS), an emerging leader in the U.S. cannabis marketplace, today provided an update to current and prospective shareholders as it embarks on a new phase of its continued efforts to augment both the quantity and quality of the cannabis produced at NUGS Farm. According to the update, Cannabis Strategic Ventures has been simultaneously targeting operational improvements in production capacity and product quality and has achieved measurable results. The Company has begun a streamlining stage in its grow operations to drive further execution gains, and the grow team at NUGS Farm has begun a process of determining strains that will make the cut in terms of long-term production capacity commitment. “We continue to drive powerful improvements in terms of execution,” Simon Yu, CEO of Cannabis Strategic Ventures, stated in the news release. “Different strains work best in different conditions. Our decision will be based on maximizing our productive yield capacity in terms of dollars. This is purely about shareholder value. We have the luxury of consistent production with some of the finest cannabis strains in the world. But our plan has always been to pare down to four optimal strains. We have already collected quite a bit of data. We will be ready to make this decision within the next 60 days or so. After that, both quantity and quality should be significantly further bolstered.”

To view the full press release, visit http://cnw.fm/s3jdC

About Cannabis Strategic Ventures

Cannabis Strategic Ventures Inc. (OTC: NUGS) is one of the largest publicly traded marijuana cultivators in the United States. The Company is Los Angeles-based and incubates, develops and partners with category leaders within the cannabis and ancillary sectors. The Firm’s NUGS brand experience provides operational and financial strategic partnerships and a range of essential services to emerging and existing Cannabis consumer brands. For more information, visit www.CannabisStrategic.com.

NOTE TO INVESTORS: The latest news and updates relating to NUGS are available in the company’s newsroom at http://cnw.fm/NUGS

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com

303.498.7722

Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Cannabis Global, Inc. (MCTC) Adds Cannabinol (“CBN”) to R&D Effort for Project Varin

Cannabis Global (OTC: MCTC), a cannabinoid and hemp extract science-forward company developing infusion and delivery technologies, today announced the expansion of its Project Varin research and development effort to include Cannabinol (“CBN”) under the umbrella of patent pending polymeric nanoparticle and nanofiber technologies developed for Tetrahydrocannabivarin (“THC-V”). According to the update, the first stage of Project Varin produced high load particles of pure THC-V, allowing Cannabis Global to now move into production of commercial quantities. CBN has been added to the production protocol as part of this second phase. “The addition of CBN to the Project Varin production schedule is an important test of our internally developed technologies,” Arman Tabatabaei, CEO of Cannabis Global, said in the news release. “We believe the production parameters developed for THC-V will apply to CBN and other manufactured cannabinoids and we will be testing this premise on our currently scheduled manufacturing run. This will be an important test of the flexibility of our manufacturing process and if successful should allow us low cost leadership over a variety of rare cannabinoids.”

To view the full press release, visit http://cnw.fm/olnP3

About Cannabis Global, Inc.

Cannabis Global, Inc., formerly known as MCTC Holdings, Inc., is a fully audited and reporting Company with the U.S. Securities & Exchange Commission, trading with the stock symbol MCTC. The Company is an emerging force in the area of cannabinoid sciences and highly bioavailable hemp and cannabis infusion technologies. The Company does not engage in the production, distribution, or sales of any controlled substances, including marijuana. The Company has an actively growing portfolio of intellectual property having filed six patents in the areas of cannabinoid delivery systems and cannabinoid polymeric nanoparticles. The Company markets its consumer products under the Hemp You Can Feel brand name. Cannabis Global launched its Project Varin early in 2020, to develop new delivery methods for rare cannabinoid Tetrahydrocannabivarin (“THC-V”) and to develop products based on this cannabinoid. For more information, visit the Company’s website at www.CannabisGlobalInc.com.

NOTE TO INVESTORS: The latest news and updates relating to MCTC are available in the company’s newsroom at http://cnw.fm/MCTC

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com

303.498.7722

Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW – Research Shows Marijuana Users Not at Higher Risk of Workplace Accidents

For the past few years, cannabis has become more mainstream as attitudes and perceptions towards it change. Plenty of states have legalized either medical and recreational use or both, making it widely accessible. However, not everyone is on the cannabis train, and plenty of employers aren’t willing to hire staff who indulge in marijuana, either medically or to unwind.

They have been encouraged in part by several studies that have found a correlation between marijuana use and workplace accidents. The results of such studies have come into question after new research showed that marijuana users aren’t at a higher risk of workplace accidents. Titled ‘Systemic Review of Cannabis Use and Risk of Occupational Injury,’ the study was published in the journal Substance Use and Misuse and it found that adults who consume marijuana are no more likely to suffer injuries at work than employees who did not consume cannabis.

Researchers from the University of British Columbia conducted a systematic review of scientific papers assessing the potential links between marijuana consumption and occupational accidents. According to the researchers, “few studies employed research designs that ensured that cannabis use preceded the occupational injury. Additionally, they say, other studies failed to adequately assess or control for confounding variables, such as the concurrent use of alcohol or other psychoactive substances.

They concluded that due to these limitations, “the current body of evidence does not provide sufficient evidence to support the position that cannabis users are at increased risk of occupational injury.” A similar study carried out by the National Academy of Sciences, Engineering, and Medicine in 2017 concluded that “there is no or insufficient evidence to support a statistical association between cannabis use and occupational accidents or injuries.”

This comes at a time when advocates have been fighting against workplace discrimination targeting employees who consume cannabis outside of work. The fact that current drug tests cannot prove exactly when THC was introduced into the system means that cannabis consumed over the weekend can get you in trouble even after it’s already worn off and you are 100% sober.

“In recent months, lawmakers in several municipalities including New York City, Richmond, Virginia, and Washington DC have enacted legislation limiting the use of marijuana-specific pre-employment drug screening,” says NORML, who first reported on the study. “Both Maine and Nevada have enacted state-specific legislation barring certain employers from refusing to hire a worker solely because he or she tested positive for cannabis on a pre-employment drug screen.”

Industry watchers believe that industry players like Sugarmade, Inc. (OTCQB: SGMD) hope that as more research about the safety of cannabis becomes available, members of the public will no longer be arbitrarily discriminated against for consuming a product with hardly any risks.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW – Why Smart Entrepreneurs Need to Consider the Marijuana Beverage Industry

The cannabis sector is without a doubt one of the top industries to keep an eye on. Still fairly young, the industry has proven that it can be quite profitable despite the myriad of challenges it still faces. However, despite having very encouraging projections, the industry will soon be filled with sellers who want a piece of the loot, and smart entrepreneurs will have to find new ways to stay on top.

One such area is cannabis beverages, a new and exciting sub-industry that takes all the natural benefits that cannabis brings and puts them in a bottle. Well, it’s not exactly new as people in places like India and China were using cannabis for centuries before it became so controversial, but it’s an exciting part of cannabis culture still. These days, people are looking for products that have natural ingredients, low caloric counts, experimental flavors, craft appeal, and offer functional benefits. Marijuana beverages check most of the boxes.

For a long time, the technology to process marijuana beverages was quite limited. Cannabinoids, the chemicals responsible for cannabis’ effects are fat-soluble, and they do not mix easily with water-based beverages. Thus cannabis sellers had to look for other avenues, settling on cannabis-infused gummies, brownies, and other confectioneries. However, the technology required to pull off cannabis-infused beverages is catching up. Technologies like nano emulsification and using cyclodextrins allow the creation of high quality, fast-acting, and longer-lasting cannabis beverages.

One thing cannabis beverages have over alcohol, sodas, and energy drinks is that they are a lot healthier. As consumers become more conscious of what they put on and in their bodies, they are becoming increasingly aware of the potential harm things like alcohol and energy drinks can cause. Cannabis, on the other hand, works by interacting with the endocannabinoid system (“ECS”), a nervous system that helps maintain homeostasis or internal balance of the body, and consuming cannabis helps boost the ECS and bring you closer to internal balance.

In fact, counties that offer residents a legal choice between alcohol and marijuana have seen a 12-15% decline in alcohol. Given the choice, consumers will ultimately choose the healthier option. And unlike smoking cannabis, which you probably shouldn’t be doing in public, beverages have no stigma attached to them. You’re free to have a drink anytime, anywhere, and without judgment. This, coupled with the fact that cannabis beverages are healthier than most drinks on the shelves and they offer a variety of health benefits makes them a very attractive and profitable option for entrepreneurs.

Analysts assert that the major marijuana industry actors like Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) are looking to go big in the beverages segment in the coming years.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

HempNewsBreaks – SinglePoint Inc. (SING) Leverages Rising Popularity of 1606 Hemp Cigarettes

SinglePoint (OTCQB: SING) recently announced plans to expand the launch of its 1606 Hemp cigarettes with a new six-pack countertop display (http://cnw.fm/9dOOJ). An article discussing the company’s new hemp initiatives reads, “‘The great thing about the hemp cigarette is, unlike tobacco, the hemp product can sit up on the counter,’ commented Lambrecht in the interview. Made from broad-spectrum, American-grown, harvested and cured hemp flower, the filtered pre-rolls are made with less than 0.3% THC and contain nearly 20% CBD in each pre-roll, providing a smooth alternative to tobacco products. With a fast-growing fan base of loyal users, the pre-rolls have seen a sales growth rate of 133% this quarter over the previous quarter along with a 233% growth in sales when compared with the same point last month. . . . ‘I was in that business for 30 years and actually took a cigar distribution company public on the Nasdaq,’ explained Lambrecht. ‘We’re really excited about this box that we developed because this box is going to be able to sit right up at the counter. We’re going to be sending that out to our extensive store list, so I think in the upcoming weeks I’m hopefully going to really have some big results on some sales from some big chains and distributors that are going to take this product on.’”

To view the full article, visit http://cnw.fm/mpNi6

About SinglePoint Inc.

Founded in 2011, SinglePoint invests in and acquires brands and companies that will benefit from injection of growth capital and the company’s sales and marketing expertise. SING’s portfolio currently includes solar, hemp and technology applications. SinglePoint is working to grow the company to a multinational brand. For more information, visit the company’s website at www.SinglePoint.com.

NOTE TO INVESTORS: The latest news and updates relating to SING are available in the company’s newsroom at http://cnw.fm/SING

About HempWire

To receive instant SMS alerts, text HEMPWIRE to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.HempWire.com

Please see full terms of use and disclaimers on the HempWire website applicable to all content provided by HW, wherever published or re-published: https://www.HempWire.com/Disclaimer

Do you have questions or are you interested in working with HW? Ask our Editor

HempWire (HW)
Denver, Colorado
www.HempWire.com
303.498.7722 Office
Editor@HempWire.net

HempWire is part of the InvestorBrandNetwork.

420 with CNW – There’s No Link Between Marijuana Use and Increased Stroke Risk, Study Finds

As more states legalize marijuana and its use becomes more prevalent, there have been numerous studies about its potential risks and benefits. In particular, there have been a number of conflicting results regarding marijuana use and increased stroke risk, with some studies stating that it reduces the risk while others argue that it exponentially increases the risk. According to a recent study by a team of neurologists at the University of Mississippi Medical Center, there is no link between increased stroke risk and marijuana use.

The team analyzed data from nearly 10,000 individuals and they found that cannabis use does not increase your risk of having a stroke. “Previous studies that investigated cannabis use and risk of stroke have had conflicting results, some showing a decreased risk and others showing a greatly increased risk,” says Carmela San Luis, MD, lead investigator and a member of the American Academy of Neurology (“AAN”).

“Our observational study looked specifically at recent cannabis use by reviewing drug testing data for people admitted to the hospital. While more research is needed with larger numbers of people, our study lends support to the studies showing that cannabis use does not increase the risk of stroke.” San Luis and a team of colleagues from the University of Mississippi in Jackson designed the study to assess potential correlations between marijuana use (a positive cannabinoid urine drug screen on admission) and a diagnosis of an acute ischemic stroke.

They studied de-identified data from 9,350 patients who were 18 years old and over admitted in the University of Mississippi Medical Center from 2015 -2017, and only 18% of the patients tested positive for cannabis use. Ischemic stroke was observed in 7.91% (130) of the 1,643 individuals who tested positive for cannabis and in 15.66% (1207) of those who tested negative. The database also granted the researchers access to information related to age, ethnicity, sickle cell disease, family history of stroke, hypertension status, obesity, diabetes mellitus, cigarette smoking, atrial fibrillation, carotid artery stenosis and other cardiac conditions. They were included as confounders in the researchers’ multivariate logistic regression analysis.

San Luis notes that the study only captured whether people had used marijuana recently and that it did not collect information on how much marijuana was consumed or any other information about their history of prior use.

“Our research adds to the list of studies with conflicting results, so it’s important to continue to investigate stroke risk and cannabis use. Future studies are now needed in larger groups of people that not only include data from drug screenings but also from dosing amounts and a person’s history of cannabis use.”

Industry watchers say the findings of such studies are of interest to sector players like SinglePoint, Inc. (OTCQB: SING) since the industry would greatly benefit once reliable third-party information is widely available on the various myths and misconceptions circulating about marijuana.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW – Why Some People May Not See Results After Consuming CBD

Over the past few years, cannabidiol (“CBD”) has gained the reputation of a cure all, and marketers have leaned quite heavily into it. Plenty of companies that process and sell CBD have taken to making all kinds of medical claims to attract customers. However, the truth of the matter is that a large portion of the evidence backing CBD’s medical abilities is anecdotal, and the cannabis extract definitely won’t fix all your health issues.

It has become immensely popular in recent years, with CBD gummies being the third most searched for food in 2018. What a lot of marketing campaigns fail to say is that for the most part, CBD reacts with different people in different ways, and another person’s experience with CBD will not exactly mirror your own. So why do some people fail to see tangible results after consuming CBD?

For starters, CBD reacts with the endocannabinoid system (“ECS”), a peripheral nervous system in charge of maintaining the homeostasis or internal balance of the body. It is made up of individual cannabinoid receptors spread throughout the body, and everyone’s ECS is unique in both its make up and level of functionality. Like a fingerprint, no two are alike, so everyone’s reaction will be slightly different based on their ECS.

While smoking or vaping cannabis has a more or less instantaneous effect, CBD can take a while, depending on the method of application. Topicals will offer quick results but if you’re ingesting your CBD, it may take you weeks of daily consistent use for the effects to kick in. A lot of the time, new users will approach it with an ‘instant gratification’ mindset, and seeing no results after a few doses, drop too soon.

Additionally, you may just be using the wrong product. Despite being only a few years old, the CBD space is filled with a huge variety of products. In broad terms, there are the full-spectrum products, which contain a host of other cannabinoids and terpenes, and there are the isolates, where all the other chemicals are stripped away to leave only CBD. Full-spectrum products are more popular as the sum of all the cannabinoids and terpenes work together in a complementary way in what has been termed the ‘entourage effect.’

Like most medicines, CBD doesn’t work in a vacuum, and you will have to put in effort for it to be effective. Eat healthy, exercise regularly, get plenty of sleep, and consistent CBD use will supplement your healthy lifestyle.

The variation in the way different people respond to CBD may be the reason why industry actors like Round Meadow Holdings Corp. and Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) encourage customers to read all the available literature before choosing a CBD product to buy.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.